Aktie A0LA7D NEXGENRX INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NexgenRx Inc.

Aktien

A0LA7D

CA65337X1042

NXG

Markt geschlossen - Toronto S.E.
Andere Börsenplätze
 17:00:00 16.04.2024 		% 5 Tage % 1. Jan.
0,2 CAD 0,00 % Intraday Chart für NexgenRx Inc. -14,89 % -9,09 %
05.04. NexgenRx Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 NEXGENRX INC. gibt den Rücktritt von Dave Bennett aus dem Vorstand bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023
NexgenRx's Q1 Profit Falls, Revenue Rises
NexgenRx Inc. Appoints Dave Bennett as New Director
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
NexgenRx Swings to Loss in Q4
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022
NexgenRx Announced Q2 2022 Financial Results
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022
NexgenRx Third-Quarter Profit Falls 15% on Higher Spending
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0LA7D Aktie
  4. Nachrichten NexgenRx Inc.
  5. Andere Sprachen